Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Life Sciences
|
May 29, 2003
A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients
M Grundman, E Capparelli, H T Kim, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study
S H Ferris, J A Mackell, R Mohs, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
MR imaging features of amyloid-related imaging abnormalities
J Barakos, R Sperling, S Salloway, et al.
Molecular Psychiatry
|
March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study
P M Doraiswamy, R A Sperling, K Johnson, et al.
Neurobiology of Disease
|
June 24, 2024
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
B N Lizama, H A North, K Pandey, et al.
Neurology
|
November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S Salloway, R Sperling, S Gilman, et al.
Neurology
|
November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial
L Teri, R G Logsdon, E Peskind, et al.
The Journal of Prevention of Alzheimer'S Disease
|
November 30, 2017
EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials
P Aisen, J Touchon, R Amariglio, et al.
The Journal of Nutrition, Health & Aging
|
April 14, 2012
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology
B Vellas, H Hampel, M E Rougé-Bugat, et al.
Neurology
|
December 24, 2010
Report of the task force on designing clinical trials in early (predementia) AD
P S Aisen, S Andrieu, C Sampaio, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Life Sciences
|
May 29, 2003
A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients
M Grundman, E Capparelli, H T Kim, et al.
Alzheimer Disease and Associated Disorders
|
January 1, 1997
A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study
S H Ferris, J A Mackell, R Mohs, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
MR imaging features of amyloid-related imaging abnormalities
J Barakos, R Sperling, S Salloway, et al.
Molecular Psychiatry
|
March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study
P M Doraiswamy, R A Sperling, K Johnson, et al.
Neurobiology of Disease
|
June 24, 2024
An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease
B N Lizama, H A North, K Pandey, et al.
Neurology
|
November 20, 2009
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S Salloway, R Sperling, S Gilman, et al.
Neurology
|
November 23, 2000
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial
L Teri, R G Logsdon, E Peskind, et al.
The Journal of Prevention of Alzheimer'S Disease
|
November 30, 2017
EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials
P Aisen, J Touchon, R Amariglio, et al.
The Journal of Nutrition, Health & Aging
|
April 14, 2012
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology
B Vellas, H Hampel, M E Rougé-Bugat, et al.
Neurology
|
December 24, 2010
Report of the task force on designing clinical trials in early (predementia) AD
P S Aisen, S Andrieu, C Sampaio, et al.
Page
of 5